ARTICLE | Company News
BioCancell management update
May 14, 2012 7:00 AM UTC
BioCancell Therapeutics Inc. (Tel Aviv:BICL), Jerusalem, Israel Business: Cancer Transitioning: Jonathan Burgin, CFO, to CEO, effective June 1; he succeeds Uri Danon, who will depart ...